Genomics are a key part of the breast surgeon’s ability to offer personalized breast cancer care to treat appropriately without causing unnecessary side effects and optimize aesthetic and functional outcomes. Breast cancer surgeons are often the first point of contact for breast cancer patients and a trusted source for guidance on overall care. DCISionRT can provide valuable information and play an important role in the shared decision-making process.